LYRA

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing drug-eluting implants for chronic rhinosinusitis and other ear, nose, and throat conditions. The company utilizes its proprietary XTreo platform to deliver sustained-release medications directly to diseased tissue in the sinonasal passages. Lyra aims to improve treatment outcomes while reducing the need for repeat procedures and systemic medications.